Why Moderna's delayed break-even goal may not even be possible

Michael Yee News

Why Moderna's delayed break-even goal may not even be possible
ModernaBiotech CompanyMarket Domination
  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 66 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 40%
  • Publisher: 63%

Shares of Moderna (MRNA) have been falling this week after the biotech company pushed back its break-even goal by two years and predicted 2025 sales to come ...

) have been falling this week after the biotech company pushed back its break-even goal by two years and predicted 2025 sales to come below its forecast for the current year. Moderna also delayed the timeline for developing key products, sending shares close to a four-year low.

"Two things are going to occur. One is that they are going to burn a significant amount of cash in that time point. We're calling for the potential risk of needing to raise capital... And the second is that we believe there's concerns over some of their projections as it relates to the pipeline. And so we just don't think that that revenue or break-even timeline is possible. We think they're going to have to raise money.

Their shares are close to a four year low, and our next guest slashed is rating on the vaccine maker to hold from by.So you you do take the rating annual hold Michael, to explain why explain the downgrade?Uh, the first, uh, was that they lowered guidance uh, for 2020 before on covid and RSB, uh, two, areas that both have been disappointing.

They now have the RSV vaccine approved, and I will even go on record to say it's very possible that the CM VA another virus, particularly that can affect babies, may have positive day in the next couple of months.I think that where we know is that it's very good for respiratory vaccines and preventing, uh, obviously respiratory diseases.And obviously part of the issue here, particularly with RSV, is that they were not able to hit any of the sales projections.And you might mention cancer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

YahooFinanceCA /  🏆 47. in CA

Moderna Biotech Company Market Domination

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shawn Mendes' fireside folk number, and 4 more songs you need to hear this weekShawn Mendes' fireside folk number, and 4 more songs you need to hear this weekShawn mendes' 'Why Why Why' is a song you need to hear this week.
Read more »

'No One Is Telling You The Truth': Woman Shares Why No One Should Go On Cruises'No One Is Telling You The Truth': Woman Shares Why No One Should Go On CruisesBefore setting sail on a cruise, make sure you understand what you’re getting yourself into!
Read more »

Woman Shares Why Cruise Ships Are The Worst, Tells Others To Never Go On OneWoman Shares Why Cruise Ships Are The Worst, Tells Others To Never Go On OneBefore setting sail on a cruise, make sure you understand what you’re getting yourself into!
Read more »

Why we think so much about the Roman Empire – and why it mattersWhy we think so much about the Roman Empire – and why it mattersThe story of the rise and fall of the ancient superpower can be pulled apart, rearranged, and interpreted to fit any number of narratives, and its lessons feel timely in modern geopolitics
Read more »

Why analysts are so often wrong in their economic estimates, and why that’s OKWhy analysts are so often wrong in their economic estimates, and why that’s OKIn March, forecasters expected 25,000 new jobs in Canada. Instead, we lost 2,200
Read more »

1st lung cancer vaccine trials launch, powered by COVID mRNA technology1st lung cancer vaccine trials launch, powered by COVID mRNA technologyThe mRNA vaccine, known as BTN116, developed by the German biotechnology company BioNTech, is the first of its kind and has entered phase 1 clinical trials in seven countries.
Read more »



Render Time: 2025-02-15 00:46:58